Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Guideline on diagnostic facet medial nerve branch blocks and facet neurotomy.

BIBLIOGRAPHIC SOURCE(S)

  • Washington State Department of Labor and Industries. Guideline on diagnostic facet medial nerve branch blocks and facet neurotomy. Provider Bull 2005 Aug;(PB 05-11):1-6. [7 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Washington State Department of Labor and Industries. Guideline on facet neurotomy. Provider Bull 2003 Sep;(PB 03-11):1-6.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Criteria for Cervical or Lumbar Facet Neurotomy

Inclusion Criteria

  CLINICAL FINDINGS
CONSERVATIVE CARE   SUBJECTIVE/OBJECTIVE   DIAGNOSTIC TESTS
Failure of 6 months of noninvasive therapy such as physical therapy, medications, or manual therapy (mobilization/manipulation) AND Non-radicular neck or back pain

AND

Segmental pain or tenderness at the level of the potentially involved facet and not more than 2 joint levels bilaterally or 3 joint levels unilaterally

AND

Neurologically intact for the region involved

OR

If neurologic deficit is present, it should be addressed in the treatment plan.
AND Diagnostic testing as required to rule out any correctable structural lesion to include CT or MRI.
Diagnostic blocks should not involve more than 2 joint levels bilaterally or 3 joint levels unilaterally.

AND

Minimum of at least 2 differential local anesthetic blocks. One block must be of the medial branch of the dorsal ramus innervating the targeted facet joints; the other block may be an intra-articular facet joint block.

AND

Differential blocks may be either 0.5 mL total volume of a short acting local anesthetic (2% to 4% lidocaine); or 0.5 mL total volume of a long acting local anesthetic (0.5% to 0.75% bupivacaine).

AND

Steroid may be used with a local anesthetic for the intra-articular block but total volume of both local and steroid should not exceed 0.5 mL for cervical injection and 0.75 mL for lumbar injection.

AND

Minimum of 80% pain relief following each block while performing activities that previously provoked pain. Documentation of pain relief should be a patient-generated report in real-time, every 15 minutes for the first six hours following the block.

AND

Duration of pain relief should be consistent with the expected duration of the local anesthetic injected (at least 1 hour for short acting and at least 2 hours for long acting local anesthetic).

AND/OR

Placebo controlled blocks may be used to resolve any ambiguity of results of local anesthetic blocks.

Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging

Exclusion Criteria That Would Require Utilization Review (UR) Physician Review

  • Radiculopathy
  • Anticipated cervical, thoracic, or lumbar surgery, or surgery for any other condition
  • Previous fusion at the targeted level
  • Diagnosed with a psychiatric condition likely to interfere with diagnostic accuracy of the workup protocol or with recovery following the anticipated procedure
  • Multiple, focal, chronic pain syndromes (i.e., complex regional pain syndrome [CRPS], fibromyalgia, chronic fatigue syndrome)
  • Intravenous (IV) sedation during a diagnostic block

Documentation of Pain Relief Following Diagnostic Medial Nerve Branch Block or Facet Joint Block

No pain medication should be taken for four hours prior to each diagnostic medial nerve branch block or facet joint block. No IV sedation should be administered before or during a diagnostic block except in an extreme case of anxiety. Prior to the block, pain should be reproducible with positioning of the patient, to at least a "4" on a 0-10 pain scale.

After each diagnostic block the injured worker must document the level of pain relief obtained using the Neurotomy Workup Pain Relief Report Form found in the original guideline document. The form may be copied as needed. The injured worker is to engage in the activities that previously produced pain and document the level of pain relief obtained every 15 minutes for a minimum of six hours following each block, or until their usual level of pain returns, whichever occurs first. The worker is to return the completed form to the physician at the next scheduled office visit. Place a copy of the Pain Relief Report Form in the medical record, send a copy to the department, and another copy to the department's utilization review vendor if a facet neurotomy is requested.

Reactivation and Maximum Medical Improvement following a Facet Neurotomy

Prior to a facet neurotomy, a formal plan for reactivation must be developed, and agreed upon by the injured worker. If indicated, vocational assessment and/or plan development should be considered prior to the procedure. Progressive reactivation, as appropriate based on the injured worker's condition, may include up to four weeks of outpatient physical therapy or occupational therapy, or work hardening.

A facet neurotomy should be the final procedure performed before an injured worker is expected to be at maximum medical improvement. Payment for repeat facet neurotomy at the same level and the same side will not be authorized. It is important that the injured worker receive a facet neurotomy when it will provide the maximum functional benefit. In almost all cases, that will be when the injured worker is about to return to work or enter vocational rehabilitation. For these reasons, at the conclusion of the post procedure reactivation period, the injured worker should be at maximum medical improvement.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

The guideline is based on a literature review of the current scientific information regarding facet neurotomy in the treatment of facet joint pain, and on expert opinion from actively practicing physicians who regularly treat facet joint pain.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Washington State Department of Labor and Industries. Guideline on diagnostic facet medial nerve branch blocks and facet neurotomy. Provider Bull 2005 Aug;(PB 05-11):1-6. [7 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2003 Sep 15 (revised 2005 Aug)

GUIDELINE DEVELOPER(S)

Washington State Department of Labor and Industries - State/Local Government Agency [U.S.]

SOURCE(S) OF FUNDING

Washington State Department of Labor and Industries

GUIDELINE COMMITTEE

Washington State Department of Labor and Industries (L&I)

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Medical Director, Washington State Department of Labor and Industries (L&I): Gary Franklin, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Washington State Department of Labor and Industries. Guideline on facet neurotomy. Provider Bull 2003 Sep;(PB 03-11):1-6.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the Washington State Department of Labor and Industries Web site.

Print copies: L&I Warehouse, Department of Labor and Industries, P.O. Box 44843, Olympia, Washington 98504-4843.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was updated by ECRI on May 26, 2004. The information was verified by the guideline developer on June 14, 2004. This summary was updated by ECRI on January 16, 2006. The updated information was verified by the guideline developer on February 2, 2006.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo